electroCore (ECOR) Projected to Post Quarterly Earnings on Wednesday

electroCore (NASDAQ:ECOR) is projected to release its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.59) per share and revenue of $9.0120 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 4:30 PM ET.

electroCore (NASDAQ:ECOR) last posted its quarterly earnings results on Thursday, March 19th. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.01. The firm had revenue of $9.24 million during the quarter, compared to analysts’ expectations of $9.09 million. electroCore had a negative return on equity of 1,956.38% and a negative net margin of 43.60%. On average, analysts expect electroCore to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

electroCore Stock Performance

NASDAQ ECOR opened at $6.64 on Monday. The stock’s fifty day moving average is $6.59 and its two-hundred day moving average is $5.84. The firm has a market capitalization of $53.65 million, a P/E ratio of -4.02 and a beta of 0.68. electroCore has a fifty-two week low of $4.16 and a fifty-two week high of $8.64.

Analyst Ratings Changes

ECOR has been the topic of several analyst reports. Zacks Research upgraded electroCore from a “strong sell” rating to a “hold” rating in a report on Friday, March 27th. Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research report on Friday, March 27th. raised shares of electroCore to a “strong-buy” rating in a research note on Tuesday, February 3rd. Finally, HC Wainwright decreased their target price on shares of electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a report on Monday, January 26th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $18.00.

Insider Transactions at electroCore

In other electroCore news, Director Daniel S. Goldberger sold 16,072 shares of electroCore stock in a transaction on Friday, April 10th. The stock was sold at an average price of $6.02, for a total value of $96,753.44. Following the sale, the director owned 291,471 shares in the company, valued at $1,754,655.42. The trade was a 5.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 13.80% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Two Sigma Investments LP boosted its stake in electroCore by 20.8% during the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after buying an additional 4,231 shares during the period. Cubist Systematic Strategies LLC acquired a new position in electroCore during the first quarter worth $153,000. Jane Street Group LLC lifted its stake in electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after acquiring an additional 19,599 shares in the last quarter. DRW Securities LLC purchased a new position in electroCore during the 4th quarter valued at about $264,000. Finally, NewEdge Advisors LLC grew its position in electroCore by 857.9% in the 1st quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock valued at $1,083,000 after acquiring an additional 145,047 shares in the last quarter. Institutional investors and hedge funds own 26.74% of the company’s stock.

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.